S. Travis King

466 total citations
29 papers, 290 citations indexed

About

S. Travis King is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, S. Travis King has authored 29 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 9 papers in Infectious Diseases and 8 papers in Pharmacology. Recurrent topics in S. Travis King's work include Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Use and Resistance (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). S. Travis King is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (6 papers), Antibiotic Use and Resistance (5 papers) and Antimicrobial Resistance in Staphylococcus (5 papers). S. Travis King collaborates with scholars based in United States, Australia and Brazil. S. Travis King's co-authors include Kayla R. Stover, Katie E. Barber, Daniel M. Riche, Ayelet Talmi, John D. Cleary, Jason M. Pogue, Jamie L. Wagner, Jessica Robinson, Daniel B. Chastain and Elizabeth Hall‐Lipsy and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Antimicrobial Agents and American Journal of Orthopsychiatry.

In The Last Decade

S. Travis King

28 papers receiving 286 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Travis King United States	12	97	74	52	44	43	29	290
Kashif Hussain Pakistan	9	64 0.7×	76 1.0×	52 1.0×	18 0.4×	16 0.4×	32	334
Emmanuel Wey United Kingdom	10	80 0.8×	157 2.1×	29 0.6×	63 1.4×	32 0.7×	24	363
Erin Balkenende United States	7	118 1.2×	83 1.1×	33 0.6×	11 0.3×	32 0.7×	21	276
Karan Varshney Australia	9	97 1.0×	65 0.9×	21 0.4×	18 0.4×	21 0.5×	36	353
Francesca Licata Italy	13	110 1.1×	140 1.9×	23 0.4×	21 0.5×	17 0.4×	45	441
Anthony J. Guarascio United States	11	111 1.1×	79 1.1×	76 1.5×	9 0.2×	25 0.6×	25	346
Thomas Dobbs United States	14	133 1.4×	75 1.0×	79 1.5×	50 1.1×	39 0.9×	40	608
Chun-Ming Lee Taiwan	11	93 1.0×	96 1.3×	79 1.5×	22 0.5×	52 1.2×	13	351
Benjamin Pei Zhi Cherng Singapore	9	244 2.5×	82 1.1×	38 0.7×	19 0.4×	12 0.3×	15	513
Heather L. VandenBussche United States	10	96 1.0×	135 1.8×	102 2.0×	10 0.2×	36 0.8×	12	356

Countries citing papers authored by S. Travis King

Since Specialization

Citations

This map shows the geographic impact of S. Travis King's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Travis King with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Travis King more than expected).

Fields of papers citing papers by S. Travis King

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Travis King. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Travis King. The network helps show where S. Travis King may publish in the future.

Co-authorship network of co-authors of S. Travis King

This figure shows the co-authorship network connecting the top 25 collaborators of S. Travis King. A scholar is included among the top collaborators of S. Travis King based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Travis King. S. Travis King is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Robins, Lisa, et al.. (2024). Oral health education strategies for patients living with cardiovascular disease within hospital settings: a scoping review. Frontiers in Public Health. 12. 1389853–1389853.

King, S. Travis, et al.. (2021). Linezolid for the Treatment of Urinary Tract Infections Caused by Vancomycin-Resistant Enterococci. SHILAP Revista de lepidopterología. 9(4). 175–175. 8 indexed citations

King, S. Travis, et al.. (2020). Ten-year review of a shared care approach in the management of ocular chlamydia trachomatis infections. Eye. 35(6). 1614–1619. 1 indexed citations

King, S. Travis, et al.. (2020). Childhood bereavement: Understanding prevalence and related adversity in the United States.. American Journal of Orthopsychiatry. 90(4). 391–405. 49 indexed citations

Tamraz, Bani, Lori Reisner, Audrey L. French, et al.. (2019). Association between Use of Methadone, Other Central Nervous System Depressants, and QT c Interval–Prolonging Medications and Risk of Mortality in a Large Cohort of Women Living with or at Risk for Human Immunodeficiency Virus Infection. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(9). 899–911. 1 indexed citations

Chastain, Daniel B., S. Travis King, & Kayla R. Stover. (2018). Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms. BMC Research Notes. 11(1). 497–497. 13 indexed citations

Jeffres, Meghan N., Elizabeth Hall‐Lipsy, S. Travis King, & John D. Cleary. (2018). Systematic review of professional liability when prescribing β-lactams for patients with a known penicillin allergy. Annals of Allergy Asthma & Immunology. 121(5). 530–536. 14 indexed citations

King, S. Travis, et al.. (2018). Newest lipoglycopeptides for the management of acute bacterial skin and skin structure infections. The Nurse Practitioner. 43(10). 31–37. 3 indexed citations

Wagner, Jamie L., et al.. (2018). Risk Factors for Failure in Complicated Intraabdominal Infections. Southern Medical Journal. 111(2). 125–132. 4 indexed citations

10.

Stover, Kayla R., S. Travis King, & Katie E. Barber. (2018). Impact of an infectious diseases advanced pharmacy practice experience on student knowledge. Currents in Pharmacy Teaching and Learning. 10(8). 1022–1025. 2 indexed citations

11.

King, S. Travis, et al.. (2017). Shifts in antimicrobial consumption and infection rates before and during a piperacillin/tazobactam shortage. Journal of Global Antimicrobial Resistance. 11. 111–113. 11 indexed citations

12.

Stover, Kayla R., et al.. (2017). Time–Kill Analysis of Ceftolozane/Tazobactam Efficacy Against Mucoid Pseudomonas aeruginosa Strains from Cystic Fibrosis Patients. Infectious Diseases and Therapy. 6(4). 507–513. 5 indexed citations

13.

Stover, Kayla R., et al.. (2017). Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp .. International Journal of Antimicrobial Agents. 50(5). 690–692. 6 indexed citations

14.

Chastain, Daniel B., S. Travis King, & Kayla R. Stover. (2016). Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection. The Open AIDS Journal. 10(1). 113–126. 2 indexed citations

15.

Barber, Katie E., et al.. (2016). Impact of piperacillin-tazobactam shortage on meropenem use: implications for antimicrobial stewardship programs. The Brazilian Journal of Infectious Diseases. 20(6). 631–634. 14 indexed citations

16.

Barber, Katie E., S. Travis King, Kayla R. Stover, & Jason M. Pogue. (2015). Therapeutic options for vancomycin-resistant enterococcal bacteremia. Expert Review of Anti-infective Therapy. 13(3). 363–377. 28 indexed citations

17.

Lu, Kevin, P. Brandon Bookstaver, Majdi N. Al‐Hasan, et al.. (2015). Evaluation of Empiric Therapy With Third-Generation Cephalosporins for Bloodstream Infections Secondary to Chromosomally-Mediated AmpC-Producing Enterobacteriaceae. Open Forum Infectious Diseases. 2(suppl_1). 1 indexed citations

18.

King, S. Travis, et al.. (2014). Daptomycin-induced rhabdomyolysis and acute liver injury. Scandinavian Journal of Infectious Diseases. 46(7). 537–540. 14 indexed citations

19.

Riche, Daniel M. & S. Travis King. (2010). Bone Loss and Fracture Risk Associated with Thiazolidinedione Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(7). 716–727. 23 indexed citations

20.

Riche, Daniel M., John D. Cleary, & S. Travis King. (2010). Medication-induced Adverse Effects: Important Concepts for the Hand Therapist. Journal of Hand Therapy. 23(2). 230–237. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact